top of page

Welcome to SageMedic

Finding The Most Promising

Treatment Path

For Cancer

 SAGE Oncotest™ functional drug response testing helps support informed cancer treatment decisions.

SAGE Oncotest™-

More Informed

Cancer Treatment Decisions 

In 10 Days

The SAGE Oncotest™ is a functional profiling assay that helps oncologists and patients understand which FDA approved treatments may be more or less appropriate for a patient's specific tumor, helping support more informed treatment decision-making. By evaluating your tumor’s resistance to a wide range of treatment options, the SAGE Oncotest delivers clinically relevant laboratory information to support more individualized treatment planning.

Current diagnostic approaches, including genomic testing, may not fully predict how an individual tumor will respond to therapy. 

The SAGE Oncotest™ evaluates a curated list of FDA-approved drugs by analyzing laboratory response patterns associated with your specific cancer. Patients can receive results within 7-10 days.

The

SAGE Oncotest™

Approach

 1

Upon receiving a patient's  fresh cancer tissue sample, we prepare testable tissue samples for laboratory evaluation.

 2

We ensure the tissue samples preserve key characteristics of the original tumor.

3

Following this, we evaluate multiple drugs using our proprietary technologies.

 4

With those results, physicians receive laboratory insights to help support treatment decisions within in 7-10 days.

Get Started Today

With The

SAGE Oncotest™

Well Before Your Surgery

If surgery is scheduled and subsequent treatment is required, contact us now to coordinate collection of a fresh tissue sample during surgery.

If Additional Treatment Guidance is Needed

If your oncology team is evaluating additional treatment options, the SAGE Oncotest™ may help provide laboratory insights to support treatment decision-making. 

The

SAGE Oncotest™

Vision

Our vision is to advance cancer care by supporting individualized treatment approaches and helping oncologists make more informed treatment decisions for each patient.

We pursue this mission through the use of functional tumor profiling to support oncology decision-making and individualized treatment planning. 

Supporting More Informed Cancer Treatment Decisions
 

bottom of page